{"version":"1.0","type":"link","title":"IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.","author_name":"Aggen DH 외","author_url":"https://prs-insight.online/author/Aggen%20DH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169108","thumbnail_width":1200,"thumbnail_height":630}